Watchtower Free coverage check

Drug reports

A source-checked report on one drug, delivered in 3 business days.

Order a fixed-price report on a marketed drug or a pipeline asset. We gather the public record, an analyst checks it against the original sources, and every fact in the report links to where it came from.

Compare the reports How ordering works
Delivery
3 business days
Review
Analyst-checked
Sources
Every fact cited
Product report
  1. Key dates1
  2. Regulatory history2
  3. Trials3
  4. Patents and generic entry4
  5. Coverage and pricing5
Sources 1Orange Book2Drugs@FDA3ClinicalTrials.gov4USPTO5CMS
Illustrative layout. Each finding carries a numbered link to its source record.

Two reports, one drug each

The product report covers the drug itself. The mention report covers how people are talking about it. Order one, or both.

Product report

Where does the drug stand?

$1,495 per drug

Delivered in 3 business days

Order a product report, $1,495

Secure card checkout by Stripe

See a sample report

Key dates
Exclusivity, patent expirations and extensions, expected trial results, and planned FDA actions
Regulatory history
Approvals, rejection letters, label changes, and required follow-up studies
Trials
Active and completed studies, status, enrollment, and posted results
Patents and generic entry
Listed patents, challenges, and generic guidance
Coverage and pricing
Medicare and Medicaid coverage, spending, and prices, where available
Company
Recent SEC filings and announcements from the drug’s sponsor

Mention intelligence report

How is the drug being discussed?

$3,250 per drug

Covers the past 12 months. Delivered in 3 business days

Order a mention report, $3,250

Secure card checkout by Stripe

See a sample report

Volume over time
Mentions by channel: news, research papers, SEC filings, social media, and podcasts or video where transcripts exist
Who is talking
The outlets, journals, and companies that mention the drug most
Themes and claims
What is being said about efficacy, safety, access, and pricing, and who is saying it
Tone
Positive, negative, and neutral coverage, shown with example quotes rather than scores alone
Notable mentions
The most significant recent articles, papers, and posts, each linked

Every report includes

  • A link from every fact to its original source
  • An analyst check before anything is sent
  • The report price credited toward a monitoring subscription started within 60 days

Add-ons

Rush deliveryDelivery in 1–2 business days+50%

From checkout to report in 3 business days

  1. 1

    Check out and name the drug

    Pay by card and tell us the drug or pipeline asset you need covered.

  2. 2

    We pull the public record

    We collect trial, FDA, patent, coverage, filing, and news records for that drug, including drugs we haven’t covered before.

  3. 3

    An analyst checks it

    Facts are checked against the original sources before anything is sent. If the public record is too thin for a useful report, we tell you first and refund in full.

Before you order

Reports draw on public sources such as ClinicalTrials.gov, FDA, USPTO, CMS, and SEC EDGAR.

See the full source list
Which drugs can I order a report on?

Most marketed drugs and pipeline assets with public records, in the U.S. and elsewhere. Early assets with only a trial registration may have too little for a full report; we confirm before delivery.

How do I pay?

By card, through Stripe’s secure checkout.

What format is the report?

A PDF with linked sources, plus the underlying tables on request.

How is the mention report collected?

From news, research papers, SEC filings, social media, and podcast and video transcripts. News and social coverage are broad samples, not a count of every mention anywhere, and the report says which channels it covers.

Do mentions of the molecule count toward a brand?

When a mention names the molecule rather than the brand, it can apply to every brand of that molecule. The report labels those mentions so they aren’t credited to one brand alone.

Need it continuously?

Watch the drug instead.

If you need to know every time something changes, a watch covers your drugs and competitors on an ongoing basis, with a weekly or monthly briefing.

Get a free coverage check